| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | -0.22 | 0.0006 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.21 | 0.0004 |
| mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | -0.16 | 0.0009 |
| mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.2 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | -0.14 | 2e-05 |
| mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.01 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.12 | 0.05 |
| mRNA | ZG-10 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.007 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.11 | 0.04 |
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | -0.11 | 0.002 |